logo-loader
viewBioasis Technologies Inc.

Bioasis Technologies secures patents in key global markets

Bioasis Technologies, Inc . (OTCQB:BIOAF) (CVE:BTI) CEO Deborah Rathjen sat down with Proactive's Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Guilford, Connecticut-based company is developing a proprietary technology to delivery therapeutics across the blood brain barrier and treating CNS disorders in brain cancers and neurodegenerative diseases.

Quick facts: Bioasis Technologies Inc.

Price: 0.1073 USD

OTCQB:BIOAF
Market: OTCQB
Market Cap: $6.81 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Loop Insights committed to helping Brick and Mortar stores...

Loop Insights (CVE: MTRX) President and CEO Rob Anson joined Steve Darling from Proactive Vancouver to discuss the company and their unique IP that helps brick and mortar business compete with online shopping. Anson talks about how they do that and also about a program they have started to...

12 hours, 18 minutes ago

2 min read